Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells

(1) Background: Transient receptor potential melastatin (TRPM4) ion channel aberrant expression or malfunction contributes to different types of cancer, including colorectal cancer (CRC). However, TRPM4 still needs to be validated as a potential target in anti-cancer therapy. Currently, the lack of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paulina Stokłosa, Anna Borgström, Barbara Hauert, Roland Baur, Christine Peinelt
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c1e2856b9b9d4b049042d1da2ff96539
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!